The increased systemic values of TNF-α, IL-1β, IL-6, IL-12, IL-23, and IL-33 (Figure 1) support the prevalence of innate pro-inflammatory mediators in the serum of subjects with a severe form of COVID-19. The gene discussed is IL1B; the disease is COVID-19.